drugset / Trial / NCT01441908
Longitudinal Study of Multi-Analyte Profile for Dyslipidemia
Non-randomizedParallel-groupOpen-labelScreening
Summary
The primary objective of this study is to determine any changes in cardiovascular risk among individuals receiving a statin by assessing their multi-analyte profile.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pravastatin | Small molecule | 40 mg | — |
| Comparator | Pravastatin | Small molecule | 80 mg | — |